John Bell

John Bell

Chairman bij IMMUNOCORE HOLDINGS PLC

Vermogen: 904 243 $ op 29-02-2024

71 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Dr. John I.
Bell, MD, is a Chairman at Immunocore Holdings Plc, a Chairman-Partnership Board at Oxford Centre for Diabetes Endocrinology & Metabolism, a Professor at University of Oxford, an Advisor at Biospring Management Partners LP, a Chairman at GMEC Management Co. Ltd., a Chairman at Office for Strategic Co-ordination of Health Research, a Chairman at The Oxford Health Alliance and a Non-Executive Director at The Jenner Institute Laboratories.
He is on the Board of Directors at Genomics England Ltd., Oxford Science Enterprises PLC, Oxford University Hospitals NHS Trust, The Gray Laboratory Cancer Research Trust, Our Future Health Uk, Rhodes Trust and The Ewelme Almshouse Charity.
Dr. Bell was previously employed as a President by Academy of Medical Sciences, a Non-Executive Director by Roche Holding AG, a Non-Executive Director by Oxagen Ltd., a Founder by The Wellcome Trust Centre for Human Genetics, an Independent Non-Executive Director by Avidex Ltd., a Non-Executive Director by F.
Hoffmann-La Roche Ltd., and a Chairman by Sensyne Health Plc.
He also served on the board at Atopix Therapeutics Ltd., Genentech, Inc. and Powderject Pharmaceuticals Plc.
He received his undergraduate degree from Magdalen College School Oxford Ltd, an undergraduate degree from the University of Alberta and a doctorate degree from Magdalen College School Oxford Ltd.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
02-01-2024 13 452 ( 0.03% ) 904 243 $ 29-02-2024

Actieve functies van John Bell

BedrijvenFunctieBegin
IMMUNOCORE HOLDINGS PLC Chairman -
Rhodes Trust Director/Board Member -
Director/Board Member -
Consultant / Advisor -
Office for Strategic Co-ordination of Health Research Chairman -
Director/Board Member -
The Ewelme Almshouse Charity Director/Board Member -
GMEC Management Co. Ltd. Chairman -
University of Oxford Corporate Officer/Principal 01-01-2002
░░░ ░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░ -
Alle actieve functies van John Bell

Eerdere bekende functies van John Bell

BedrijvenFunctieEinde
░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
Ervaring van John Bell in detail bekijken

Opleiding van John Bell

Magdalen College School Oxford Ltd Doctorate Degree
University of Alberta Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van John Bell in detail bekijken

Connecties

100 +

Eerstegraads connecties

27

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
ROCHE HOLDING AG

Health Technology

SENSYNE HEALTH PLC

Commercial Services

IMMUNOCORE HOLDINGS PLC

Health Technology

Bedrijven in privébezit21

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Rhodes Trust

Commercial Services

Commercial Services

The Wellcome Trust Centre for Human Genetics

Oxford Centre for Diabetes Endocrinology & Metabolism

Oxford University Hospitals NHS Trust

Miscellaneous

The Gray Laboratory Cancer Research Trust

Commercial Services

GMEC Management Co. Ltd.

The Ewelme Almshouse Charity

Health Technology

Commercial Services

Office for Strategic Co-ordination of Health Research

Finance

Finance

Commercial Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. John Bell